The lipoprotein-associated phospholipase A2 inhibitor Darapladib sensitises cancer cells to ferroptosis by remodelling lipid metabolismMihee Oh, Eun‐Woo Lee, Youngae Jung et al.|Nature Communications|2023Cited by 91
Darapladib, a lipoprotein-associated phospholipase A2 inhibitor, sensitises cancer cells to ferroptosis by remodelling lipid metabolismMihee Oh, Eun‐Woo Lee, Seo Young Jang et al.|Figshare|2023Cited by 0